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subtle white matter alterations in 
schizophrenia identified with a new 
measure of fiber density
philipp Stämpfli  1,2, Stefan sommer1,2, Andrei Manoliu1,7,8, Achim Burrer1, André schmidt3, 
Marcus Herdener4, Erich seifritz1, Stefan Kaiser5 & Matthias Kirschner1,4,6
Altered cerebral connectivity is one of the core pathophysiological mechanism underlying the 
development and progression of information-processing deficits in schizophrenia. To date, most 
diffusion tensor imaging (DTI) studies used fractional anisotropy (FA) to investigate disrupted 
white matter connections. However, a quantitative interpretation of FA changes is often impeded 
by the inherent limitations of the underlying tensor model. A more fine-grained measure of white 
matter alterations could be achieved by measuring fiber density (FD) - a novel non-tensor-derived 
diffusion marker. This study investigates, for the first time, FD alterations in schizophrenia patients. 
FD and FA maps were derived from diffusion data of 25 healthy controls (HC) and 21 patients with 
schizophrenia (SZ). Using tract-based spatial statistics (TBSS), group differences in FD and FA were 
investigated across the entire white matter. Furthermore, we performed a region of interest (ROI) 
analysis of frontal fasciculi to detect potential correlations between FD and positive symptoms. As a 
result, whole brain TBSS analysis revealed reduced FD in SZ patients compared to HC in several white 
matter tracts including the left and right thalamic radiation (TR), superior longitudinal fasciculus 
(SLF), corpus callosum (CC), and corticospinal tract (CST). In contrast, there were no significant FA 
differences between groups. Further, FD values in the TR were negatively correlated with the severity 
of positive symptoms and medication dose in SZ patients. In summary, a novel diffusion-weighted data 
analysis approach enabled us to identify widespread FD changes in SZ patients with most prominent 
white matter alterations in the frontal and subcortical regions. Our findings suggest that the new FD 
measure may be more sensitive to subtle changes in the white matter microstructure compared to FA, 
particularly in the given population. Therefore, investigating FD may be a promising approach to detect 
subtle changes in the white matter microstructure of altered connectivity in schizophrenia.
In the last decades, advanced magnetic resonance imaging (MRI) techniques have started to shed light on the 
complex brain abnormalities observed across all stages of schizophrenia1–3. Convergent findings from functional 
and structural imaging studies suggest that alterations in cerebral connectivity may be the core pathophysiolog-
ical mechanism underlying the development and progression of information processing deficits in schizophre-
nia4–7. In recent years, diffusion-weighted imaging methods were used to investigate the white matter (WM) 
integrity as anatomical correlate of this disconnection hypothesis1,8. The most commonly assessed parameter 
in DTI studies is the fractional anisotropy (FA). Emerging evidence suggest that connectivity in frontal regions 
seems to be most affected1,9–12. Critically, FA alterations in these frontal tracts, including the thalamic radiation 
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(TR), the superior longitudinal fasciculus (SLF), and arcuate fasciculus, have been related to positive psychotic 
symptoms and deepens our understanding of the relation between disconnectivity and symptom expression13–19.
However, it has been shown that the tensor model and therefore FA measures are inadequate to character-
ize the underlying tissue structure in regions with complex fiber geometries and multiple fiber populations20–25. 
Voxels capturing these anatomical complexities occur frequently (60%-90% of all WM fiber voxels) throughout 
the brain WM due to limited spatial resolution and partial volume effects between adjacent tracts25. Although a 
reduction of FA is often thought to reflect axonal degeneration and demyelination26–29, complex fiber configura-
tions may critically confound the interpretation of changes in tensor-derived diffusion metrics and complicate a 
correct and quantitative interpretation of changes in DTI-related parameters25,30–34.
In the last few years, diffusion acquisition techniques and data analysis pipelines improved significantly by 
addressing these inherent problems of the tensor model. Higher order diffusion models based on acquisition 
schemes with high number of diffusion directions and new reconstruction methods as the constrained spherical 
deconvolution technique35 were developed. These advances enable the resolution multiple fiber directions within 
a single voxel and improved the performance of fiber tractography significantly36–38. Additionally, there is a grow-
ing literature on removing tractography biases which is a crucial prerequisite to derive absolute and quantitative 
measures from fiber tractograms39,40.
However, the reliable extraction of quantitative measures from tractograms across different populations 
remains challenging. Recent developments in global top-down tractography optimizations enable the estimation 
of fiber contributions and compartment fractions41–46, whereby all of these optimization methods have their own 
pitfalls (please see the article of Daducci and colleagues for a comprehensive review47). Numerous models based 
on diffusion weighted imaging have been proposed to estimate parameters related to the restricted, intra-axonal 
compartment, commonly referred to as fiber density (FD)48,49. In the work of Smith et al. and Daducci and col-
leagues44,46, an optimal weight for each streamline is determined according to a biologically motivated forward 
model and the measured diffusion signal. By assigning a weight of zero, false positive or implausible connections 
can be eliminated. The FD is calculated by multiplying each streamline contribution (fiber weight) by the stream-
line length.
Previously, we have demonstrated that white matter alterations were more prominent in FD compared to FA 
in patients with a progressive neurological disease (amyotrophic lateral sclerosis)50.
However, the potential advantages of the aforementioned innovations in basic neuroimaging methods have 
not been established for clinical neuroscience research of pathologies in schizophrenia. It is unknown whether 
microstructural white matter fiber changes can be quantified with the new FD measure. Therefore, in the present 
study, we applied a novel whole brain TBSS analysis approach51 to test its potential in detecting microstructural 
alterations in FD between patients with schizophrenia and healthy controls. We hypothesize that, compared to 
FA, the new FD measure will be more able to detect microstructural WM changes in schizophrenia. Furthermore, 
based on previous findings13,14, we investigated the relation between FD changes in the frontal fasciculi and pos-
itive psychotic symptoms to explore the association between microstructural changes and symptom expression.
Materials and Methods
Participants. We recruited patients with chronic schizophrenia (SZ) (n = 21) from inpatient and outpatient 
units of the Psychiatric University Hospital in Zurich and from affiliated institutions. Healthy controls (HC) 
(n = 25) were recruited from the general community. Inclusion criterion for patients with SZ was schizophre-
nia or schizoaffective disorder confirmed with the structured Mini International Neuropsychiatric Interview for 
DSM IV (MINI). Individuals with any other Axis I DSM IV disorder, in particular major depression or cur-
rent substance use disorder, were excluded from the study. All individuals with SZ were clinically stable and 
received a stable dose of second-generation antipsychotic, with no change in medication dose for at least two 
weeks. The study was approved by the local ethics committee of the Canton Zurich. All participants signed the 
written informed consent in accordance with the Declaration of Helsinki. The capability of all patients to give 
informed consent was evaluated by the treating psychiatrist. One patient with SZ had to be secondarily excluded 
due to insufficient data quality caused by excessive head motion (see section on data quality assessment). Thus, 20 
chronic SZ patients were included in the subsequent analysis.
Psychopathological and neuropsychological assessment. All study participants underwent an 
extensive psychopathological and neuropsychological assessment. We assessed symptom severity with the 
Positive and Negative Syndrome Scale (PANSS)52 and functioning with the Global Assessment of Functioning 
scale (GAF)53. Moreover, all participants performed a comprehensive neuropsychological test battery, which has 
been used in previous studies54–57. We assessed verbal learning (Auditory Verbal Learning Memory Test)58 ver-
bal and visual short-term working memory59, Corsi block-tapping60, processing speed (Digit-Symbol Coding)61, 
planning (Tower of London)62 and semantic and phonetic fluency (animal naming, s-words)63. Results of all 
cognitive tests were summarized in a composite cognition score computed with the mean of z-transformed 
scores (based on HC group data). Additionally, we used the Multiple Word Test64 to control for premorbid verbal 
intelligence.
MRI data acquisition. MRI data acquisition was performed on a 3T whole-body MR scanner (Achieva, Philips 
Healthcare, Best, the Netherlands), equipped with 80 mT/m gradients and a 32-channel receive head coil. Diffusion 
data were acquired using a diffusion-weighted single-shot spin-echo echo-planar imaging sequence (ssh SE-EPI 
sequence) with the following parameters: repetition time (TR) = 6.64 s, echo time (TE) = 53.6 ms, field of view 
(FOV) = 240 × 240 mm2, 50 contiguous transversal slices, slice thickness = 2.5 mm, acquisition matrix = 96 × 96, 
SENSE factor = 2.5, partial Fourier encoding = 60%. The slices were positioned parallel to the anterior and posterior 
commissure defined on a T1-weighted midline sagittal survey image. Diffusion acquisition was performed along 32 
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directions with a b-value of 1000 s/mm2 and two signal averages (NSA = 2). Additionally, 4 non-diffusion-weighted 
b = 0 s/mm2 scans were acquired resulting in a scan time of 8 min 31 s. For structural reference and anatomical priors 
for the tracking algorithm, T1-weighted images were recorded using a three-dimensional magnetization prepared 
rapid gradient-echo (MP-RAGE) sequence with 1 mm isotropic resolution.
Data quality assessment. All data processing steps are illustrated in Fig. 1. First, diffusion data was cor-
rected for “eddy” current-induced image distortions and subject motion using the eddy tool65 in FSL (Analysis 
Group, FMRIB, Oxford, UK, version 5.0.6)66. The brain extraction tool from FSL67 was applied to remove 
non-brain tissue from the diffusion data and to estimate the inner and outer skull surfaces. Then, quality control 
of all diffusion data was assessed based on several criteria: First diffusion tensor residuals were calculated for 
every acquired diffusion direction and the nine slices in the whole diffusion dataset with the highest residuals 
were identified for visual inspection. Second, the MRtrix3 software package (http://www.mrtrix.org)68 was used 
to estimate the voxel-wise noise using the residuals from a truncated spherical harmonics fit. Plots were generated 
depicting the twelve slices with the highest noise level, four in sagittal, four in axial, and four in coronal direc-
tion, respectively. Third, mean signal intensity plots for every diffusion direction and the non-diffusion-weighted 
image were derived and plotted slice by slice in sagittal, axial, and coronal directions. Artifacts such as signal 
dropouts due to head motion can easily be spotted on these plots. Two trained MR physicists separately inspected 
the data for artefacts and rated the signal courses and fitting residuals of every subject on a Likert-type scale. 
Only one patient showed severe signal dropouts in multiple diffusion directions and several slices caused by head 
motion. Consequently, this patient was an outlier in the overall sum of the Likert-scale quality ranking scores and 
had to be excluded for the subsequent analyses.
Diffusion data analysis and parameter calculation. FD and FA Computation. In order to improve 
alignment to the T1-derived tissue priors, the diffusion data were corrected for susceptibility-induced image 
distortions69. Afterwards, constrained spherical deconvolution with recursive calibration of the response func-
tion35,70 and fiber tractography was performed in MRtrix368 using the iFOD2 probabilistic tractography algo-
rithm71. In order to apply biological tissue priors to the streamline generation, the “Anatomically-Constrained 
Tractography” (ACT) option was selected (MRtrix3 tckgen act option)40. Tractography seed points were deter-
mined dynamically according to the spherical-deconvolution informed filtering of the tractogram model 
(MRtrix3 tckgen seed-dynamic option for determining seed points based on the SIFT model43). Due to this 
dynamic seeding strategy within the whole white matter, the distribution of streamlines is already approximating 
the apparent fiber density and therefore, intrinsic tractography biases are reduced. In total, five million fibers were 
generated per subject.
The resulting streamlines were optimized using the COMMIT framework46 applying the parameters described 
in the article from Sommer and colleagues72. The derived intracellular compartment fraction corresponds to the 
FD. Furthermore, FA maps of every dataset were calculated with the FSL software package66.
Comparison between intra-subject variability of FD and FA. In order to provide evidence that the 
intra-subject variability and reproducibility of the FD measure is comparable to the FA73,74, we assessed the coef-
ficients of variation (CoV) of both measures in an independent longitudinal data set of 36 healthy subjects. Each 
subject was measured at two time points with 7 days between the first and second scan. Details of this analysis can 
be found in the supplementary materials section. In brief, the CoV of the FD and FA were small with mean values 
Figure 1. Data processing pipeline. All data processing steps performed on the diffusion and the T1 weighted 
anatomical data are illustrated in the flowchart. All tools and parameters applied on the raw data up to the final 
statistical maps are described and referenced in detail.
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less or equal 2% (Table S1). As described previously for the FA by Vollmar et al. and Veenith and colleagues73,74, these 
findings provide first evidence for high intra-subject reproducibility of the new FD measure in longitudinal data.
TBSS analysis. TBSS analysis was performed to assess differences between the healthy control group and 
patients with chronic SZ using the standard processing steps as described by Smith and colleagues51. First, all 
native FA maps were nonlinearly registered to a 1 × 1 × 1 mm3 MNI152 template. The FA maps were averaged to 
create a mean FA map, which was thereafter skeletonized to build a FA skeleton that represents the main tracts 
common to all subjects. Finally, this FA skeleton was thresholded at a FA value of 0.2.
The FD images were analyzed using the “tbss_non_FA” command (as described in the TBSS user guide 
(https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TBSS/UserGuide)). This step is the standard algorithm of the TBSS frame-
work for scalar diffusion maps other than FA maps. In other words, the FD images were analyzed with the same 
nonlinear registration-, warping-, and skeleton projection operations used during the processing of the corre-
sponding FA images51.
To evaluate differences between the groups, voxel-wise analysis based on a general linear model was per-
formed using FSL’s randomize tool75 with 5000 permutations to correct for multiple comparisons (age and gender 
were used as regressors of no interest in the design). A family wise error (FWE) corrected p-value of p < 0.05 
was considered statistically significant. The TBSS results included threshold-free cluster enhancement76. Two 
contrasts were computed, testing for positive and negative differences of the FA and FD parameters between the 
healthy control and the patient group. Furthermore, we addressed potential associations between fiber density 
and current medication dose in all clusters showing significant FD differences in the TBSS analysis between HC 
and SZ by correlating the FD values with chlorpromazine equivalents (mg/d).
Correlation Analysis with positive psychotic symptoms. In addition to the whole brain TBSS analy-
sis, we performed a region of interest (ROI) analysis to evaluate correlations between alterations in fiber density 
and symptom severity in patients with chronic SZ. The ROI analysis was based on previous DTI studies inves-
tigating the association between WM changes and positive psychotic symptoms in frontal fasciculi13,14. Within 
these frontal regions, we restricted our ROI analysis to regions showing FD differences between HC and patients 
with chronic SZ in the whole brain analysis. The following five fasciculi were included: the left and right thalamic 
radiation (TR), the left and right superior longitudinal fasciculus (SLF), and the right uncinate fasciculus (UF). 
As opposed to the TBSS method, the ROI approach estimates the integrity of entire ROIs, rather than the central 
integrity of the tracts only and has the advantage of a higher regional sensitivity as compared to a whole brain, 
voxel-based method.
ROI definition. The five anatomical ROIs defining these five major fiber tracts were obtained from a probabilis-
tic tractography atlas (JHU white-matter tractography atlas77). In total, the JHU white-matter tractography atlas 
describes 20 major fiber bundles. The probability-weighted mean FD values were calculated for each of the five 
fiber tracts by multiplying the probability-weighted maps of the individual tract with co-registered FD maps from 
the TBSS analysis. In other words, the probability tract maps served as ROIs to extract the FD values within each 
of the five fiber bundles. These mean FD values were then correlated with the PANSS positive score of patients 
with chronic SZ. Bonferroni correction was applied to correct for multiple comparison across the five predefined 
anatomical ROIs.
Results
Demographics and clinical Data. For demographic and clinical data please see Table 1. Patients with 
chronic SZ and HC did not differ in age, gender, handedness, educational years and premorbid verbal intelligence 
(MWT IQ). In contrast, we found a significant difference in the composite cognition score derived from our 
neuropsychological test battery.
Differences in FD and FA value between HC and patients with chronic schizophrenia. Patients 
with chronic SZ showed a significantly reduced FD in several brain regions compared to HC (Fig. 2 and Table 2). 
The affected tracts were the right and left TR, the right and left SLF, the right and left corticospinal tract (CST), 
the body of the corpus callosum (CC), and the right inferior fronto-occipital fasciculus (IFOF). In contrast, no 
significant group differences in FA were detectable at a whole-brain level. However, with a more liberal threshold 
of p < 0.1, FA difference between chronic SZ patients and HC were detectable in the similar brain regions of our 
FD analysis. No increased FD or FA values were found in patients with chronic SZ compared to the HC group.
Differences in FD and FA value between patients with first episode psychosis and patients with 
schizophrenia. In an explorative analysis, we tested whether the FD TBSS analysis approach enables us to 
detect microstructural white matter differences between chronic and early stage of the schizophrenia spectrum. 
We hypothesized that patients with chronic schizophrenia would show greater FD alterations compared to first 
episode patients. To test this hypothesis, we analyzed data from 14 patients with first episode psychosis (FEP) 
(for demographics see Table S2). Please note, that these data were collected with the completely same acquisition 
parameters as the HC and chronic SZ group. We performed a whole brain FD group comparison between patients 
with FEP and patients with chronic SZ. In several brain regions the FD was significantly reduced in patients with 
chronic SZ compared to patients with FEP (Table S3 and Figure S1). The pattern of the most affected regions were 
similar to our previous analysis between HC and chronic SZ patients including the left ATR; left SLF, the left CST. 
Again, we observed no significant group differences in FA values. Within the psychosis spectrum, our FD TBSS 
analysis approach revealed significant microstructural changes between patients with chronic SZ and early stages 
of psychosis. No significant differences were detectable between the HC and FEP patients. Please see the supple-
mentary material section for more details regarding this analysis.
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Healthy Controls 
(n = 25) SZ patients (n = 20) Test statistics p value
Age 32.1 (8.6) 32.7 (8.3) U = 236.0 0.749
Gender (f, m) 9, 16 4, 16 Χ2 = 1.385 0.239
Handedness (r, l) 21, 4 16, 4 χ2 = 0.122 0.725
Education, Years (SD) 12.5 (3.5) 12.1 (3.5) U = 239.5 0.806
Duration of illness, Months (SD)a 119 (87.8)
Chlorpromazine Equivalents (mg/d) 493.3 (379.9)
Psychopathology
PANSS Total 48.9 (11.3)
PANSS Positive 10.7 (2.4)
PANSS Negative 15.3 (5.9)
PANSS General 22.9 (5.3)
BNSS Total 25.7 (12.2)
BNSS Apathyb 16.1 (6.5)
BNSS Diminished Expressionc 9.6 (7.5)
GAF 55.3 (11.1)
Cognition
Cognition Scored 0.06 (0.53) −0.44 (0.94) t = 2.025 0.054
MWT IQ 27.8 (4.1) 26.7 (6.2) t = 0.657 0.516
Table 1. Demographic, Psychopathological and Clinical Data. Note: Data are presented as means and standard 
deviations. Group differences were investigated using 2-sample t tests for continuous and χ2 tests for categorical 
data. For non-normally distributed data Mann–Whitney U tests were applied. PANSS, Positive and Negative 
Syndrome Scale; BNSS, Brief Negative Symptom Scale; GAF, Global Assessment of Functioning; MWT IQ, 
Multiple Word Test Intelligence Quotient. aDuration of illness included the duration of untreated psychosis 
and the time period since initiation of treatment. bBNSS Apathy = Avolition, Anhedonia, Asociality; cBNSS 
Diminished Expression = Affective Flattening or Blunting, Alogia. dCognition data were z-transformed based 
on the data of the HC group for each test separately. The Composite cognition score was computed as the mean 
of the z-transformed test scores on subject level.
Figure 2. Whole brain differences in FD HC > SZ. TBSS results of the comparison of the FD values between 
SZ patients and healthy controls. Clusters exhibiting statistically significant decreases in the patient population 
(p < 0.05) are shown in red on the green TBSS FA skeleton.
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Relation between reduced fiber density and positive psychotic symptoms. We found a sig-
nificant correlation between mean FD values in the right TR and positive psychotic symptoms (rs = −0.522, 
p = 0.018) as well as a trend-level effect in the left TR (rs = −0.424, p = 0.063) in schizophrenia patients (Table 3, 
Fig. 3). However, when adjusting for multiple comparison, the correlation in the right TR did not survive sig-
nificance (rs = −0.522, Bonferroni adjusted p = 0.090). No significant correlation between positive psychotic 
symptoms and mean FD were observed in one of the other ROIs (Table 3). Given the fact that antipsychotic med-
ication correlated significantly with the severity of positive symptoms (rs = 0.478, p = 0.033), we performed an 
additional correlation analysis with chlorpromazine equivalents and mean FD values of the five predefined ROIs. 
Antipsychotic medication significantly correlated with mean FD values in the right TR (rs = −0.516, p = 0.02). In 
all other regions, we did not find any significant association with antipsychotic medication (left TR, rs = −0.179, 
p = 0.45 left SLF, rs = −0.371, p = 0.107; right SLF, rs = −0.364, p = 0.115).
Finally, in an explorative analysis, we investigate potential association with negative symptoms and the mean 
FD values in the TR and SLF. Neither the BNSS apathy factor (left TR, rs = −0.131, p = 0.581; right TR, rs = 0.114, 
p = 0.632; left SLF, rs = 0.248, p = 0.291; right SLF, rs = 0.226, p = 0.339; righ UF, rs = −0.13, p = 0.586) nor the 
BNSS diminished expression factor (left TR, rs = −0.223, p = 0.344; right TR, rs = −0.066, p = 0.784; left SLF, 
rs = 0.035, p = 0.885; right SLF, rs = 0.083, p = 0.728, righ UF, rs = −0.136, p = 0.566) correlated significantly with 
the FD in the TR, SLF and right UF.
Cluster 
Size (Voxel) Max X Max Y Max Z Structures to which each cluster belongs to*
5678 −21 −5 14 Superior longitudinal fasciculus, Corticospinal tract, Thalamic radiation
2914 31 −15 24 Superior longitudinal fasciculus, Inferior fronto-occipital fasciculus, Corticospinal tract, Inferior longitudinal fasciculus, Thalamic radiation, Uncinate fasciculus
199 27 22 20 Inferior fronto-occipital fasciculus, Thalamic radiation
Table 2. Significant TBSS whole brain FD group differences HC > SZ. *Only tracts with >1% probability are 
included in the labels (tracts with highest probability are listed first) and only clusters containing >10 voxels are 
reported. The statistical threshold was set to whole-brain cluster-level FWE p < 0.05.
Structural ROIs Spearman rank correlation p-value
left TR rs = −0.424 0.063
right TR rs = −0.522 0.018
left SLF rs = −0.299 0.201
right SLF rs = −0.311 0.182
right UF rs = 0.002 0.992
Table 3. Correlations between positive psychotic symptoms and FD in predefined ROIS. Spearman rank 
correlations (rs) between FD values in predefined ROIs and positive symptoms measured with the. PANSS 
Positive Score.
Figure 3. Correlation between fiber density in the thalamic radiation and positive symptoms. Spearman rank 
correlations (rs) between FD values in in the right and left thalamic radiation and positive symptoms (PANSS 
Positive Score) (rs = −0.522, p = 0.018; left: rs = −0.424, p = 0.063).
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Discussion
The present study tested a novel diffusion data analysis approach to detect alterations in WM fiber density in 
patients suffering from SZ. We found widespread microstructural FD changes in chronic SZ patients in com-
parison to HCs. The reduction in FD was most prominent in frontal and subcortical regions including the TR, 
the SLF, CC, and CST. Critically, patients with chronic SZ showed reduced FD not only compared to HC but also 
in comparison to patients with early stage of psychosis. This suggests that FD alterations propagate during the 
disease course of schizophrenia. In contrast, FA values did not differ significantly between SZ patients and HC or 
SZ and patients with FEP. Thus, the FD may have advantages to identify subtle changes of WM fibers compared 
to the FA. This hypothesis is underpinned by the fact that reduced FA values in patients with chronic SZ observed 
at a more liberal threshold (p < 0.1) follow a similar regional pattern as the reduced FD findings. Finally, FD 
alterations in the TR were associated with the severity of positive psychotic symptoms and medication dose. The 
present study introduced a useful diffusion data analysis approach, which could foster the progress to identify 
the complex nature of WM microstructure alterations in schizophrenia. Our findings contribute to the existing 
MR diffusion literature suggesting that WM alterations are a structural substrate of core information-processing 
deficits in schizophrenia7,8,78.
Benefits of FD analysis for the interpretation of microstructural correlates. Measures of struc-
tural integrity inferred from DTI-based calculations, such as the commonly used FA value, are affected by the 
inherent problem of the diffusion tensor. In particular, the diffusion tensor may not be able to characterize the 
underlying tissue structure accurately, especially in voxels containing complex fiber configurations20–25. The 
new developed FD measure benefits from recent advances of higher order diffusion models, improved tractog-
raphy algorithms35,40,44,68, state of the art tractogram optimization techniques46, and microstructural diffusion 
models79–81. By combining these analyzing methods, new white matter measures such as FD can be established. 
Critically, these measures better represent the underlying WM fiber structure even in voxels containing complex 
fiber architectures and could overcome the limitations of other quantitative, tensor-derived measures (for an 
extensive review, see the works of Pettersson-Yeo et al. and Jones3,30). Thus, the FD might be suitable to detect 
subtle WM fiber alteration in schizophrenia and other neuropsychiatric disorders.
However, intra-subject variability and reproducibility are crucial issues when comparing two structural brain 
measures. In particular, it is important to ensure that the intra-subject variability and reproducibility of the new 
measure (here FD) exhibits the same characteristics as the established measure (here FA) under comparison. By 
comparing the CoV of the FA and the FD in an independent longitudinal data set, we provide initial evidence for 
a comparable accuracy of the new FD measure and the FA. These findings suggest a high reproducibility of the FD 
although larger non-clincial and clinical longitudinal data are needed.
FD changes relation to frontal dysconnectivity in schizophrenia. In line with the growing evidence 
for altered WM integrity in frontal and temporal regions in patients with schizophrenia1,3,9,11 the most promi-
nent FD reduction were observed in tracts connecting subcortical and frontal as well as temporal and frontal 
regions. Critically, the altered FD of the TR, ILF and IFOF is supported by meta-analytic evidence for reduced 
WM volume and FA in these regions9,82 and recent studies comparing patients with SZ and patients with bipolar 
disorder83. In addition to these reports of WM alterations, there is meta-analytic evidence for reduced frontal and 
thalamic grey matter volume in schizophrenia9. This suggests an association between altered WM microstructure 
in thalamo-cortical connection and reduced grey matter volume of these interconnected regions. In accordance 
with these consistent structural abnormalities, there is growing evidence that frontal functional dysconnectiv-
ity, in particular thalamo-cortical dysconnectivity, is a core neurobiological abnormality in schizophrenia3,12,84. 
Thalamo-cortical dysconnectivity has been consistently reported not only in chronic patients, but even in early 
psychosis and individuals at clinical high risk stages85,86. Taken together, this accumulating evidence suggests a 
strong association between structural and functional frontal dysconnectivity in schizophrenia. However, mul-
timodal neuroimaging studies combining DWI with fMRI are needed to elucidate the direct interplay between 
structural and functional alterations.
Frontal FD alterations as neural substrate for positive symptoms. In the present sample, deficits 
in WM microstructure of the fronto-thalamic pathway were most prominent in patients with higher positive 
symptoms. Several previous studies reported an association between positive symptoms and altered WM integ-
rity in different fronto-temporal pathways including the TR, arcuate fasciculus, SLF, UF and IFOF13,14,87,88. With 
respect to the fronto-thalamic pathway, the association between positive psychotic symptoms and reduced FD 
is in accordance with a trend-wise correlation in a recent large meta-analytic DTI analysis89. In addition, rest-
ing state FMRI studies showed that fronto-thalamic disconnectivity is associated with psychotic symptoms86. 
Furthermore, a specific role of the arcuate fasciculus and the SLF in the development of auditory hallucinations 
has been proposed14,16,17,90. The lack of association between SLF and positive symptoms in the present study may 
be explained by the fact that the PANSS positive symptom score cover several items other than auditory verbal 
hallucinations. However, the association between positive symptoms and reduced FD in the fronto-thalamic 
pathway supports the hypothesis that alterations in long-range association tracts projecting in the frontal lobe 
may be a core structural substrate of general information processing deficits in psychosis3,13,78.
Potential medication effects on FD. In the present study positive symptoms were highly associated with 
current antipsychotic dose and reduced FD in the TR was also correlated with antipsychotic medication. In a 
cross-sectional design, we are not able to differentiate between specific effects of symptom expression or poten-
tial confounding effects of higher medication doses in patients with more severe positive symptoms. A recent 
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longitudinal study showed that reduced FA in the TR was restored after 6 weeks of amisulpride treatment (D2/3 
receptor blockade)13 suggesting that second generation antipsychotics may protect against WM alterations91,92. 
This is supported by a recent naturalistic study in which microstructural WM changes recovered after success-
ful treatment in drug-naïve patients93. However, other recent longitudinal studies are inconclusive; increase94, 
decrease95, or no effect96,97 of medication on FA values have all been reported. Furthermore, the largest DTI 
cross-sectional study and meta-analysis in the field to date did not find any effects of medication dosage on WM 
integrity89. However, findings from a recent small sample study suggest a medication effects depending on the dif-
ferent drug type (clozapine, other atypical, typical)98. The present study is the first investigating FD in medicated 
patients with SZ. Therefore, future studies in unmedicated patients and longitudinal treatment studies would be 
very valuable to clarify the role of antipsychotic medication on the microstructural changes in FD.
Limitations and future directions. Some limitations of this study should be considered. First, although 
we observed robust whole-brain FD differences between HC and patients with chronic SZ, the small sample size 
might have limited our ability and power to identify specific clinical correlates of reduced FD at our given alpha 
level. The same issue potentially accounts for the lack of group differences between HC and patients with FEP in 
our explorative analysis. Future studies with larger sample sizes should try to elucidate whether FD changes are 
specific to frontal and temporal tracts or reflect a more global deficit in schizophrenia. Furthermore, larger studies 
across the complete schizophrenia spectrum are needed to investigate whether FD alterations occur only in later 
disease stages or are also prevalent in early psychosis and ultra-high risk states. Second, all patients received a 
stable dose of second-generation antipsychotics. Although, previous studies did not find any effect of medication 
and duration of illness on WM integrity89, both factors may affect the FD in patients with chronic SZ. Therefore, 
studies in unmedicated patients would be very valuable to identify the role of medication on FD changes. Third, 
in order to acquire all data within a clinically feasible scan time suitable to a clinical population, a rather short 
diffusion protocol with only 32 directions and a single b-value of 1000 s/mm2 had to be used. Several techniques 
were applied to overcome the limitations of the rather small number of diffusion directions: (1) a probabilistic 
tractography algorithm was chosen, and (2) the final tractogram for each subject was derived from 5 million 
streamlines, which were then optimized by the COMMIT framework. The fact that the diffusion data only con-
sisted of a single shell did not compromise the COMMIT optimization with respect to the intracellular compart-
ment fraction (referred to as FD). However, in order to reliably distinguish multiple isotropic compartments with 
different diffusion times (e.g. gray-matter and cerebrospinal fluid), it would be crucial to acquire multi-shell diffu-
sion data. Fourth, compared to traditional, tensor-based models, the derivation of the new FD is computationally 
more intensive. However, all steps, except the final TBSS processing, can be executed in subject space on cloud 
computing infrastructures. Thus, computation time can be reduced dramatically, and state of the art computer 
infrastructures allow FD estimation even for large-scale data. Lastly, while there is converging evidence from 
structural and functional connectivity studies supporting the disconnectivity hypothesis of schizophrenia, com-
bined DWI and fMRI studies are needed to elucidate the structural substrates of information processing deficits.
Conclusion
The present study found that estimating FD values show great promise as detailed and quantitative measure for 
WM integrity changes in schizophrenia. Critically, this new FD parameter may be more suitable to detect micro-
structural WM changes compared to the FA value. Thus, FD detection may foster the progress to evaluate the 
pathological processes of altered connectivity in schizophrenia.
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